Related Experiment Video
Updated: Dec 21, 2025
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo
Kyongman An1, Igor Klyubin, Youngkyu Kim
1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Gyungbuk 790-784, Korea. joungkim@postech.ac.kr.
Background:
Exosomes, small extracellular vesicles of endosomal origin, have been suggested to be involved in both the metabolism and aggregation of Alzheimer's disease (AD)-associated amyloid β-protein (Aβ). Despite their ubiquitous presence and the inclusion of components which can potentially interact with Aβ, the role of exosomes in regulating synaptic dysfunction induced by Aβ has not been explored.
Results:
We here provide in vivo evidence that exosomes derived from N2a cells or human cerebrospinal fluid can abrogate the synaptic-plasticity-disrupting activity of both synthetic and AD brain-derived Aβ. Mechanistically, this effect involves sequestration of synaptotoxic Aβ assemblies by exosomal surface proteins such as PrPC rather than Aβ proteolysis.
Conclusions:
These data suggest that exosomes can counteract the inhibitory action of Aβ, which contributes to perpetual capability for synaptic plasticity.
Insights
Exosomes counteract Alzheimer's disease (AD) amyloid-beta (Aβ) toxicity. These vesicles protect synaptic plasticity by sequestering harmful Aβ aggregates, offering a potential therapeutic avenue for AD.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Exosomes, small extracellular vesicles, are implicated in Alzheimer's disease (AD) amyloid-beta (Aβ) metabolism and aggregation.
- The specific role of exosomes in Aβ-induced synaptic dysfunction remains largely unexplored.
Purpose of the Study:
- To investigate the in vivo role of exosomes in modulating Aβ-induced synaptic dysfunction.
- To determine the mechanism by which exosomes affect Aβ's impact on synaptic plasticity.
Main Methods:
- In vivo studies using exosomes from N2a cells and human cerebrospinal fluid.
- Assessment of exosome effects on both synthetic and AD brain-derived Aβ.
- Investigation of exosome-Aβ interactions, focusing on surface protein binding.
Main Results:
- Exosomes effectively abrogate the synaptic plasticity-disrupting activity of Aβ.
- Exosomes sequester synaptotoxic Aβ assemblies via surface proteins like PrPC.
- This effect occurs independently of Aβ proteolysis.
Conclusions:
- Exosomes play a protective role against Aβ-induced synaptic dysfunction.
- Exosomes can counteract the inhibitory effects of Aβ on synaptic plasticity.
- This highlights exosomes as potential therapeutic agents for maintaining synaptic function in AD.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
